1[1]Kent DM, Lau J, Selker HP. Balancing the benefits of primary angioplasty against the benefits of thrombolytic therapy for acute myocardial infarction: the importance of timing. Eff Clin Pract. 2001,4(5): 214-220.
5[5]Polonski L, Gasior M, Wasilewski J, et al. Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardialinfarction. Am Heart J,2003,145(5): 855-861.
6[6]Hermiller JB, Davidson C J, Aguirre FV, et al. Lesiondirected administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty. Cathet Cardiovasc Diagn,1996, 37(4): 382-391.
7[7]Pereg D, Behar S, Battler A, et al. Thrombolytic therapy or primary coronary angioplasty in acute myocardial infarction? Israel Thrombolytic Survey Group. Harefuah,2000, 138( 11 ) :939-944.
9[9]Vermeer F, Oude-Ophuis A J, vd Berg EJ, et al.Prospective randomised comparison between thrombolysis,rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospitalwithout PTCA facilities: a safety and feasibility study.1999,82(4): 426-431.
2Tiefenbrunn AJ, Chandra MC, French WJ, et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI- 2)[J]. J Am Coll Cardial, 1998, 31:1240-1245.
3The AHAun. Collaboration with the International Liaison Committee on Resuscitation (IL - COR). 7: the ear d reperfusion. Section 1 : acute coronary syndromes (acute myocardial infarctlon)[J]. Circulation, 2000,102(suppl): I- 172- I- 203.
4Nemnann F- J, Kastrati A, Schmitt C, et al. Effect of glycoprotein Ⅱ b/Ⅲ a receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute.myocardial infarction[J]. J Am Coll Cardial, 2000, 35:915-921.
5Morishima I, Sone T, Okumure K, et al. Angiographic no - reflow phenomenon: as a predictor of adverse long- term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction[J]. J Am Coll Cardial, 2000, 36:1202 - 1209.
6Assali AR, Sdringola S, Ghani M, et al. lntracoronary adeno - sine administerd during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no- reflow" phenomenon[J]. Catheter Cardiovasc Interv, 2000, 51:27-31.
7Jeffrey L, Labors A, Lewis C, et al. TIMI petfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction[J]. Circulation, 1993, 87:1829 - 1839.
8Ross AM, Coyne KS, Reiner JS, et al. A randomized trial[J] comparing primary angioplasty with a strategy d short - acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial[J]. J Am Coll Cardial, 1999, 34: 1954- 1962.
9Gibson CM,Cannon CP,Daley WL,et al.TIMI frame count: a quantitative method of assessing coronary artery flow[].Circulation.1996
10Spaulding C,Cador R,Benhamda K,et al.One-week and sixmonth angiographic controls of stent implantation after occlusive and nonocclusive dissection during primary balloon angioplasty for acute myocardial infarction[].The American Journal of Cardiology.1997
3[2]Newby LK,Rutsch WR,Califf RM,et al.For the GUSTO-1 investigators:time from symptom onset to treatment and outcomes after thrombolytic therapy.J Am Coll Cardiol,1996,27:1646-1655.
4[6]The TIMI Research Group.Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction:TIMI Ⅱ A results.JAMA,1988,260:2849-2858.
5[7]Yuzurihara T,Mizuo H,Miyagi Y.Novel modified human tissue plasminogen activators with prolonged plasma clearance in vivo.Thromb Haemost,1989,62:543.
